α2-肾上腺素能受体的体内外表征方法

A. L. Hudson, E. S. J. Robinson, M. D. Lalies, R. J. Tyacke, H. C. Jackson, D. J. Nutt
{"title":"α2-肾上腺素能受体的体内外表征方法","authors":"A. L. Hudson,&nbsp;E. S. J. Robinson,&nbsp;M. D. Lalies,&nbsp;R. J. Tyacke,&nbsp;H. C. Jackson,&nbsp;D. J. Nutt","doi":"10.1111/j.1365-2680.1999.tb00003.x","DOIUrl":null,"url":null,"abstract":"<div>\n \n <p><b>1</b> In order to more fully understand the role of the α<sub>2</sub>-adrenoceptor in brain function, a combination of <i>in vitro</i> and <i>in vivo</i> techniques were utilized including radioligand binding, autoradiography, brain microdialysis and antisense oligonucleotides.</p>\n <p><b>2</b> Binding studies showed the tritiated form of the selective α<sub>2</sub>-adrenoceptor antagonist, RX821002 (methoxy-idazoxan) labelled an apparent single population of sites in rat brain membranes with high affinity (1 nM), for which prazosin had low affinity (1107 nM). Similar studies in rabbit brain membranes found that prazosin and oxymetazoline were able to displace. [<sup>3</sup>H]-RX821002 in a biphasic manner indicating the presence of subtypes of α<sub>2</sub>-adrenoceptors.</p>\n <p><b>3</b> Receptor autoradiography revealed a distribution of [<sup>3</sup>H]-RX821002 binding in rat brain consistent with the labelling of all %aL<sub>2</sub>-adrenoceptor subtypes, namely α<sub>2A/D</sub>-, α<sub>2B</sub> and α<sub>2C</sub>.</p>\n <p><b>4</b> In rat, <i>in vivo</i> brain dialysis experiments demonstrated peripherally administered RX821002 elevated basal noradrenaline in frontal cortex and also, although to a lesser extent, in ventral hippocampus. RX821002 was also able to elevate extracellular dopamine in the striatum.</p>\n <p><b>5</b> A 7-day i.c.v. infusion of an antisense oligonucleotide targeting the α<sub>2A/D</sub>-adrenoceptor, resulted in a significant reduction in the autoradiographic density of [<sup>3</sup>H]-RX821002 binding in specific brain areas, notably the lateral septal nuclei and anterior hypothalamic area.</p>\n <p><b>6</b> Several years of research by our group has extended our knowledge of the pharmacology and function of the α<sub>2</sub>-adrenoceptor and has provided evidence of the roles of this receptor in the control of monoamine turnover. The successful use of antisense technology to knockdown expression of the α<sub>2A/D</sub> subtype provides future opportunities to explore the physiology of this receptor subtype.</p>\n </div>","PeriodicalId":100151,"journal":{"name":"Autonomic and Autacoid Pharmacology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2009-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/j.1365-2680.1999.tb00003.x","citationCount":"28","resultStr":"{\"title\":\"In vitro and in vivo approaches to the characterization of the α2-adrenoceptor\",\"authors\":\"A. L. Hudson,&nbsp;E. S. J. Robinson,&nbsp;M. D. Lalies,&nbsp;R. J. Tyacke,&nbsp;H. C. Jackson,&nbsp;D. J. Nutt\",\"doi\":\"10.1111/j.1365-2680.1999.tb00003.x\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n <p><b>1</b> In order to more fully understand the role of the α<sub>2</sub>-adrenoceptor in brain function, a combination of <i>in vitro</i> and <i>in vivo</i> techniques were utilized including radioligand binding, autoradiography, brain microdialysis and antisense oligonucleotides.</p>\\n <p><b>2</b> Binding studies showed the tritiated form of the selective α<sub>2</sub>-adrenoceptor antagonist, RX821002 (methoxy-idazoxan) labelled an apparent single population of sites in rat brain membranes with high affinity (1 nM), for which prazosin had low affinity (1107 nM). Similar studies in rabbit brain membranes found that prazosin and oxymetazoline were able to displace. [<sup>3</sup>H]-RX821002 in a biphasic manner indicating the presence of subtypes of α<sub>2</sub>-adrenoceptors.</p>\\n <p><b>3</b> Receptor autoradiography revealed a distribution of [<sup>3</sup>H]-RX821002 binding in rat brain consistent with the labelling of all %aL<sub>2</sub>-adrenoceptor subtypes, namely α<sub>2A/D</sub>-, α<sub>2B</sub> and α<sub>2C</sub>.</p>\\n <p><b>4</b> In rat, <i>in vivo</i> brain dialysis experiments demonstrated peripherally administered RX821002 elevated basal noradrenaline in frontal cortex and also, although to a lesser extent, in ventral hippocampus. RX821002 was also able to elevate extracellular dopamine in the striatum.</p>\\n <p><b>5</b> A 7-day i.c.v. infusion of an antisense oligonucleotide targeting the α<sub>2A/D</sub>-adrenoceptor, resulted in a significant reduction in the autoradiographic density of [<sup>3</sup>H]-RX821002 binding in specific brain areas, notably the lateral septal nuclei and anterior hypothalamic area.</p>\\n <p><b>6</b> Several years of research by our group has extended our knowledge of the pharmacology and function of the α<sub>2</sub>-adrenoceptor and has provided evidence of the roles of this receptor in the control of monoamine turnover. The successful use of antisense technology to knockdown expression of the α<sub>2A/D</sub> subtype provides future opportunities to explore the physiology of this receptor subtype.</p>\\n </div>\",\"PeriodicalId\":100151,\"journal\":{\"name\":\"Autonomic and Autacoid Pharmacology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2009-01-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1111/j.1365-2680.1999.tb00003.x\",\"citationCount\":\"28\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Autonomic and Autacoid Pharmacology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/j.1365-2680.1999.tb00003.x\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Autonomic and Autacoid Pharmacology","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/j.1365-2680.1999.tb00003.x","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 28

摘要

为了更充分地了解α2肾上腺素能受体在脑功能中的作用,我们采用了放射配体结合、放射自显影、脑微透析和反义寡核苷酸等体外和体内结合技术。2结合研究表明,选择性α2-肾上腺素能受体拮抗剂RX821002(甲氧基-咪唑嗪)的tritriated形式在大鼠脑膜上具有高亲和力(1 nM)的单一位点,而吡唑嗪具有低亲和力(1107 nM)。对兔脑膜的类似研究发现,吡唑嗪和羟甲唑啉能够置换。[3H]-RX821002呈双相表达,表明存在α2-肾上腺素受体亚型。3受体放射自显影显示[3H]- rx821002结合在大鼠脑内的分布与所有% a2 -肾上腺素能受体亚型α2A/D-、α2B和α2C的标记一致。在大鼠中,体内脑透析实验表明,外周给药RX821002提高了额叶皮质的基础去甲肾上腺素,尽管程度较小,但也提高了腹侧海马的基础去甲肾上腺素。RX821002也能提高纹状体的细胞外多巴胺。5 . 7天静脉滴注一种靶向α2A/ d肾上腺素能受体的反义寡核苷酸,可显著降低[3H]-RX821002在特定脑区结合的放射自显影密度,尤其是中隔外侧核和下丘脑前部区。我们小组几年来的研究扩展了我们对α2肾上腺素能受体的药理学和功能的认识,并提供了该受体在控制单胺转换中的作用的证据。成功利用反义技术敲低α2A/D亚型的表达为未来探索该受体亚型的生理学提供了机会。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
In vitro and in vivo approaches to the characterization of the α2-adrenoceptor

1 In order to more fully understand the role of the α2-adrenoceptor in brain function, a combination of in vitro and in vivo techniques were utilized including radioligand binding, autoradiography, brain microdialysis and antisense oligonucleotides.

2 Binding studies showed the tritiated form of the selective α2-adrenoceptor antagonist, RX821002 (methoxy-idazoxan) labelled an apparent single population of sites in rat brain membranes with high affinity (1 nM), for which prazosin had low affinity (1107 nM). Similar studies in rabbit brain membranes found that prazosin and oxymetazoline were able to displace. [3H]-RX821002 in a biphasic manner indicating the presence of subtypes of α2-adrenoceptors.

3 Receptor autoradiography revealed a distribution of [3H]-RX821002 binding in rat brain consistent with the labelling of all %aL2-adrenoceptor subtypes, namely α2A/D-, α2B and α2C.

4 In rat, in vivo brain dialysis experiments demonstrated peripherally administered RX821002 elevated basal noradrenaline in frontal cortex and also, although to a lesser extent, in ventral hippocampus. RX821002 was also able to elevate extracellular dopamine in the striatum.

5 A 7-day i.c.v. infusion of an antisense oligonucleotide targeting the α2A/D-adrenoceptor, resulted in a significant reduction in the autoradiographic density of [3H]-RX821002 binding in specific brain areas, notably the lateral septal nuclei and anterior hypothalamic area.

6 Several years of research by our group has extended our knowledge of the pharmacology and function of the α2-adrenoceptor and has provided evidence of the roles of this receptor in the control of monoamine turnover. The successful use of antisense technology to knockdown expression of the α2A/D subtype provides future opportunities to explore the physiology of this receptor subtype.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Issue Information Autonomic and Autacoid Pharmacology: Goodbye and thank you Attenuation of the anti-contractile effect of cooling in the rat aorta by perivascular adipose tissue Retraction: Dopamine receptor immunohistochemistry in the rat choroid plexus. Issue Information
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1